These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7127336)

  • 21. Etoposide (VP-16-213).
    Issell BF; Crooke ST
    Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
    [No Abstract]   [Full Text] [Related]  

  • 22. Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood.
    Rivera G; Bowman WP; Look AT; Evans WE; Kalwinsky D; Dahl GV
    Cancer Treat Rev; 1982 Jun; 9 Suppl():53-7. PubMed ID: 6181873
    [No Abstract]   [Full Text] [Related]  

  • 23. Etoposide as single agent and in combination with cis-platinum for malignant lymphomas.
    Kroner T; Obrecht JP; Jungi WF
    Cancer Treat Rev; 1982 Jun; 9 Suppl():39-43. PubMed ID: 6889920
    [No Abstract]   [Full Text] [Related]  

  • 24. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
    Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
    Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
    Havemann K
    Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
    [No Abstract]   [Full Text] [Related]  

  • 26. An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer.
    Rubin J; Decker DA; Ahmann DL; Eagan RT; Ingle JN; Hahn RG
    Oncology; 1980; 37(3):149-51. PubMed ID: 7360486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma.
    Newlands ES; Bagshawe KD
    Eur J Cancer (1965); 1980 Mar; 16(3):401-5. PubMed ID: 6154579
    [No Abstract]   [Full Text] [Related]  

  • 28. PHASE I clinical trial of an oral solution of VP-16-213.
    Nissen NI; Dombernowsky P; Hansen HH; Larsen V
    Cancer Treat Rep; 1976 Jul; 60(7):943-5. PubMed ID: 1009527
    [No Abstract]   [Full Text] [Related]  

  • 29. Adva-27a, a novel podophyllotoxin derivative found to be effective against multidrug resistant human cancer cells.
    Merzouki A; Buschmann MD; Jean M; Young RS; Liao S; Gal S; Li Z; Slilaty SN
    Anticancer Res; 2012 Oct; 32(10):4423-32. PubMed ID: 23060568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
    Gockerman JP; Bartolucci AA; Nelson MO; Silberman H; Velez-Garcia E; Stein R
    Cancer Treat Rep; 1986 Jun; 70(6):801-2. PubMed ID: 3524829
    [No Abstract]   [Full Text] [Related]  

  • 31. Etoposide (VP-16) in the treatment of lung cancer.
    Pedersen AG; Hansen HH
    Cancer Treat Rev; 1983 Dec; 10(4):245-64. PubMed ID: 6318994
    [No Abstract]   [Full Text] [Related]  

  • 32. The epipodophyllotoxin derivatives VM26 and VP16: experimental and clinical aspects.
    Dombernowsky P; Hansen HH
    Eur J Haematol Suppl; 1988; 48():49-57. PubMed ID: 3073960
    [No Abstract]   [Full Text] [Related]  

  • 33. VP16-213 and cyclophosphamide in advanced breast cancer. A phase II study.
    Estapé J; Cirera L; Millá A; Doncel F
    Cancer Chemother Pharmacol; 1983; 10(3):154-7. PubMed ID: 6861258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
    Sanz Ortíz J; Saiz García F
    Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
    [No Abstract]   [Full Text] [Related]  

  • 35. VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.
    Tempero M; Kessinger A; Lemon HM
    Cancer Clin Trials; 1981; 4(2):155-7. PubMed ID: 6265110
    [No Abstract]   [Full Text] [Related]  

  • 36. [New antineoplastic drugs of the podophyllotoxin derivative group].
    Robak T; Płuzańska A
    Pol Tyg Lek; 1983 Jan; 38(1):27-30. PubMed ID: 6346283
    [No Abstract]   [Full Text] [Related]  

  • 37. VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer.
    Eagan RT; Carr DT; Frytak S; Rubin J; Lee RE
    Cancer Treat Rep; 1976 Jul; 60(7):949-51. PubMed ID: 64298
    [No Abstract]   [Full Text] [Related]  

  • 38. Etoposide: a new anti-cancer agent.
    Arnold AM; Whitehouse JM
    Lancet; 1981 Oct; 2(8252):912-5. PubMed ID: 6117692
    [No Abstract]   [Full Text] [Related]  

  • 39. Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
    Athanassiades P; Bacoyiannes H; Kontoyiannes D
    Chemioterapia; 1986 Apr; 5(2):125-7. PubMed ID: 3518965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
    Lopez JA; Mann J; Grapski RT; Nassif E; Vannicola P; Krikorian JG; Finkel H
    Cancer Treat Rep; 1985 Apr; 69(4):369-71. PubMed ID: 2986833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.